يعرض 1 - 10 نتائج من 88 نتيجة بحث عن '"Chronic Obstructive Pulmonary Diseases"', وقت الاستعلام: 1.32s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8

    المصدر: Acta Pharmaceutica Sinica. B
    Guo, Y, Bera, H, Shi, C, Zhang, L, Cun, D & Yang, M 2021, ' Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines ', Acta Pharmaceutica Sinica B, vol. 11, no. 8, pp. 2565-2584 . https://doi.org/10.1016/j.apsb.2021.05.015Test
    Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2565-2584 (2021)

    مصطلحات موضوعية: PLA, polylactic acid, MPP, mucus-penetrating particles, PLGA, poly(lactic-co-glycolic acid), Review, CS, chitosan, Pulmonary exposure, MW, molecular weight, PVA, polyvinyl alcohol, 0302 clinical medicine, Inhaled sustained release formulations, BALF, bronchoalveolar lavage fluid, General Pharmacology, Toxicology and Pharmaceutics, Patient compliance, COPD, chronic obstructive pulmonary diseases, HA, hyaluronic acid, DPIs, dry powder inhalers, 0303 health sciences, DPPC, dipalmitoylphosphatidylcholine, FDA, US food and drug administration, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Obstructive Pulmonary Diseases, API, active pharmaceutical ingredient, NLCs, nanostructured lipid carriers, Clearance, medicine.medical_specialty, LABA, long-acting β2-adrenoceptor agonist, RM1-950, IL-5, interleukin-5, PCL, poly-ε-caprolactone, 03 medical and health sciences, LPPs, large porous particles, medicine, FDKP, fumaryl diketopiperazine, Intensive care medicine, Pharmaceutical strategies, Systemic diseases, Da, aerodynamic diameters, 030304 developmental biology, Asthma, PEG, polyethylene glycol, Lung, PVA - Polyvinyl alcohol, business.industry, DSPC, 1,2-distearoyl-sn-glycero-3-phosphocholine, Therapeutic effect, Drug administration, Pulmonary clearance pathways, MP, mucoadhesive particles, medicine.disease, Pulmonary drug delivery, SLNs, solid lipid nanoparticles, PDD, pulmonary drug delivery, Tmax, time of maximum concentration, ALIS, amikacin liposomal inhalation suspension, Mn, number-average molecular weight, MDIs, metered dose inhalers, Pulmonary safety, IL-4, interleukin-4, MCE, mucociliary escalator, PK, pharmacokinetics, Therapeutics. Pharmacology, ELF, epithelial lining fluid, business, Local lung diseases

    وصف الملف: application/pdf

  9. 9
  10. 10